Amphastar Pharmaceuticals, Inc. (AMPH) is a renowned American-based biopharmaceutical company focusing on the development, manufacturing, and sale of generic and proprietary injectable, inhalation, and intranasal products. The company was incorporated in 1996 and is headquartered in Rancho Cucamonga, California.
Amphastar Pharmaceuticals provides its products to hospitals, care organizations, international healthcare facilities, and clinics that need generic and specialized pharmaceuticals for their patients. The company's broad portfolio includes products used in areas such as critical care, cardiac care, trauma care, and respiratory health. Some of the primary active pharmaceutical ingredients in its products include heparin, lidocaine, lorazepam, and morphine.
The company's extensive range of products includes Enoxaparin Sodium Injection, a generic anticoagulant; Amphadase, hyaluronidase injection; and Cortrosyn, a diagnostic drug. The company is known for its devotion to research and development, with many new products usually in various stages of development. Besides, Amphastar Pharmaceuticals holds several patent protections for its technologically innovative and clinically useful pharmaceutical products.
Amphastar Pharmaceuticals has grown substantially over the years. It operates manufacturing facilities in California, Indiana, and even internationally in France, China, and also owns a research and development facility in Canada. Furthermore, the company made headlines when it acquired International Medication Systems, Limited in 2005, and Merck’s active pharmaceutical ingredient manufacturing facility in France in 2009. These acquisitions have bolstered the company's manufacturing capabilities and expanded its market access.
Moreover, the company remains financially robust, generating substantial revenues from the sale of its pharmaceuticals. It has a healthy stock market listing with its shares traded on the NASDAQ.
However, the company isn't just about profits; it is dedicated to improving patient care by delivering high-quality, affordable medications that address unmet medical needs. As well, Amphastar Pharmaceuticals places great importance on core values such as integrity, innovation, and commitment, thus enhancing its corporate reputation in the healthcare industry.
In summary, Amphastar Pharmaceuticals, Inc. stands out as a formidable player in the pharmaceutical industry, continually striving to make important contributions to global healthcare. The company's commitment to research, along with its dedication to quality and affordability, has not only led it to its current success but also set a firm foundation for future achievements.